Lisa Vercollone
Biographic Data
| ID | 5416705 |
|---|---|
| NAME | Lisa Vercollone |
| GIVEN NAMES | Lisa |
| FAMILY NAME | Vercollone |
| SIGNATURE | VERCOLLONE L |
| AFFILIATIONS | Brigham and Women's Hospital |
| ORCID | 0009-0008-9226-9379 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 1 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 1 |
Ketamine treatment for buprenorphine-precipitated opioid withdrawal
Ketamine may be an effective adjunctive agent in managing opioid withdrawal. Usually restricted to the intensive care unit and emergency department, this case report highlights both the potential and risks of IV ketamine on the general hospital floors. Further research is needed to better understand the safety of using ketamine to manage opioid withdrawal
Phosphatidylethanol levels and their association with withdrawal severity among individuals with severe alcohol use disorder seeking inpatient withdrawal management
Consistent with prior reports, PEth levels appear to correlate with patients' alcohol consumption including heavy drinking, but our results did not find that PEth levels predict alcohol withdrawal severity among heavy drinkers seeking inpatient withdrawal management. Further research is warranted to better understand the utility of PEth testing
Outcomes for Patients Discharged to Involuntary Commitment for Substance Use Disorder Directly from the Hospital
Outcomes for Patients Discharged to Involuntary Commitment for Substance Use Disorder Directly from the Hospital
Ketamine treatment for buprenorphine-precipitated opioid withdrawal
Ketamine may be an effective adjunctive agent in managing opioid withdrawal. Usually restricted to the intensive care unit and emergency department, this case report highlights both the potential and risks of IV ketamine on the general hospital floors. Further research is needed to better understand the safety of using ketamine to manage opioid withdrawal
Phosphatidylethanol levels and their association with withdrawal severity among individuals with severe alcohol use disorder seeking inpatient withdrawal management
Consistent with prior reports, PEth levels appear to correlate with patients' alcohol consumption including heavy drinking, but our results did not find that PEth levels predict alcohol withdrawal severity among heavy drinkers seeking inpatient withdrawal management. Further research is warranted to better understand the utility of PEth testing
Medicine (3 works) · Psychiatry (3 works) · Alcohol (2 works) · Alcoholism and Thiamine Deficiency (2 works) · Internal Medicine (2 works) · Opioid Use Disorder Treatment (2 works) · Substance Abuse Treatment and Outcomes (2 works) · Alcohol consumption (1 work) · Alcohol Consumption and Health Effects (1 work) · Alcohol dependence (1 work)